|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Amortization of debt discount and issuance costs | |||||
| Payment-in-kind interest | |||||
| (Gain) loss on debt extinguishment | |||||
| Unrealized (gain) loss on foreign currency exchange | |||||
| Accretion on short-term investments | |||||
| Non-cash operating lease expenses | |||||
| Amortization of creator signing fees | |||||
| Changes related to creator advances, creator signing fees, and allowance for credit losses | |||||
| Provision for chargebacks and refunds | |||||
| Gain on litigation settlement | |||||
| Other | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Funds receivable | |||||
| Creator signing fees and creator advances | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable, creators | |||||
| Accounts payable | |||||
| Chargebacks and refunds reserve | |||||
| Accrued compensation and benefits | |||||
| Accrued taxes | |||||
| Operating lease liabilities | |||||
| Other accrued liabilities | |||||
| Payment-in-kind interest | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of short-term investments | |||||
| Maturities of short-term investments | |||||
| Purchases of property and equipment | |||||
| Capitalized internal-use software development costs | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Repayment of debt obligations | |||||
| Proceeds from issuance of debt | |||||
| Principal repayment of debt obligations and prepayment premium | |||||
| Purchase of convertible notes capped calls | |||||
| Debt issuance costs | |||||
| Repurchase of common stock | |||||
| Proceeds from exercise of stock options | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Other | |||||
| Proceeds from issuance of common stock under ESPP | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash | |||||
| Beginning of period | |||||
| End of period | |||||
| Supplemental cash flow data | |||||
| Interest paid | |||||
| Income taxes paid, net of refunds | |||||
| Noncash investing and financing activities | |||||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Reduction of right-of-use assets due to modification or exit | |||||
| Purchases of property and equipment included in accounts payable, trade and other accrued liabilities | |||||
Loading...